Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ThermoGenesis has gained approval for its AXP AutoXpress Platform used for the processing of cord blood in Thailand and expects to launch commercial activities latter in 2012.
Subscribe to our email newsletter
ThermoGenesis chief executive officer Matthew Plavan said the approval is an important step in the company’s strategy to expand the geographic reach of its products.
"The number of cord blood banks per capita in urban areas of Thailand exceeds that of many larger countries in the region," Plavan added.
"We believe this reflects the country’s appreciation for the clinical benefits of cord blood stem cells, which should translate into high demand for quality processing and storage as the country adopts automation."
ThermoGenesis develops and manufactures automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products.